CAS No. |
552830-51-0 |
中文名称 |
(5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-三羟基二十碳-6,8,10,14,16-五烯酸 |
英文名称 |
(5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoic acid |
别名 |
RvE1 | (5S,12R,18R)-trihydroxy-(6Z,8E,10E,14Z,16E)-icosapentaenoic acid | AKOS040742539 | CS-0064920 | 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid | J2.218.407E | UNII-GND3JH08JA | 6,8,10,14,16-Eicosapentaenoic acid, 5,12,18-trihydroxy-, |
标准英文名 |
(5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoic acid |
分子式 |
C20H30O5 |
分子量 |
350.45
|
精确分子量 |
350.21
|
SMILES |
CC[C@@H](O)\C=C\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O |
标准SMILES |
CC[C@@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(O)=O |
用途 |
Resolvin E1 (RvE1) is a potent pro-resolving mediator derived from the omega-3 fatty acid eicosapentaenoic acid (EPA). It is endogenously biosynthesized from EPA in the presence of aspirin during the spontaneous resolution phase of acute inflammation, involving specific cell-cell interactions. RvE1 exhibits unique counter-regulatory actions by inhibiting polymorphonuclear leukocyte (PMN) transendothelial migration. It also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production. |
InChIKey |
AOPOCGPBAIARAV-OTBJXLELSA-N |